June 9, 2020 / 12:29 PM / 25 days ago

BRIEF-Veracyte Announces De Novo Classification Request To FDA For The Ncounter Dx Lymphmark Assay

June 9 (Reuters) - Veracyte Inc:

* VERACYTE ANNOUNCES DE NOVO CLASSIFICATION REQUEST TO FDA FOR THE NCOUNTER DX LYMPHMARK ASSAY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below